IntelGenx Technologies (IGXT) News Today $0.17 0.00 (0.00%) As of 03/31/2025 Add Compare Share Share Headlines Stock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Intelgenx Technologies (OTC:IGXT) Stock Quotes, Forecast and News SummaryAugust 18, 2024 | benzinga.comIntelGenx Technologies Corp.: IntelGenx Provides Update on Previously Announced Sale and Investment Solicitation ProcessJuly 20, 2024 | finanznachrichten.deIntelGenx Provides Update on Previously Announced Sale and Investment Solicitation ProcessJuly 19, 2024 | globenewswire.comIntelGenx Obtains Preliminary Efficacy Results for the ‘BUENA' Montelukast VersaFilm® Phase 2a Clinical Trial in Patients with Mild to Moderate Alzheimer's DiseaseJuly 3, 2024 | globenewswire.comIntelGenx Announces Initiation of the Sale and Investment Solicitation ProcessJune 11, 2024 | globenewswire.comIntelGenx Obtains Court-Approval of a Sale and Investment Solicitation ProcessMay 28, 2024 | globenewswire.comIntelGenx Initiates Restructuring Proceedings Under the CCAA to Implement a Review of its Strategic AlternativesMay 17, 2024 | globenewswire.comIntelGenx Initiates Restructuring Proceedings Under the CCAA to Implement a Review of its Strategic AlternativesMay 17, 2024 | globenewswire.comIntelGenx Announces Voting Results on Election of DirectorsMay 8, 2024 | globenewswire.comIntelGenx Announces First Parkinson’s Disease Patients Dosed with Montelukast VersaFilm® in Phase 2 ‘MONTPARK’ Clinical TrialApril 8, 2024 | finance.yahoo.comIntelGenx Announces First Parkinson's Disease Patients Dosed with Montelukast VersaFilm® in Phase 2 ‘MONTPARK' Clinical TrialApril 8, 2024 | globenewswire.comIntelGenx Updates Status of Buprenorphine Buccal Film ANDAApril 5, 2024 | globenewswire.comIntelGenx Technologies Corp. (IGXT) Q4 2023 Earnings Call TranscriptMarch 23, 2024 | seekingalpha.comIntelGenx Technologies Corp. (PNK:IGXT) Q4 2023 Earnings Call TranscriptMarch 22, 2024 | insidermonkey.comIGXT Stock Earnings: Intelgenx Technologies Reported Results for Q4 2023March 21, 2024 | investorplace.comIntelGenx Reports Fourth Quarter and Full-Year 2023 Financial ResultsMarch 21, 2024 | globenewswire.comIGXT IntelGenx Technologies Corp.March 16, 2024 | seekingalpha.comIntelGenx to Report Fourth Quarter and Full Year 2023 Financial Results on March 21, 2024 – Conference Call to FollowMarch 14, 2024 | globenewswire.comIntelGenx Enters Into a Third Amended and Restated Loan Agreement With atai Life SciencesMarch 11, 2024 | globenewswire.comUPDATE -- IntelGenx Launches Preferred Share Regulation A OfferingFebruary 20, 2024 | finance.yahoo.comUPDATE -- IntelGenx Launches Preferred Share Regulation A OfferingFebruary 20, 2024 | globenewswire.comIntelGenx Launches Preferred Share Regulation A OfferingFebruary 20, 2024 | globenewswire.comIntelGenx Technologies Corp. (IGXT)February 19, 2024 | finance.yahoo.comStudies Validate Advantages of Administering Drugs to Pets via IntelGenx’s VetaFilm® PlatformFebruary 5, 2024 | finance.yahoo.comIntelgenx Technologies Corp IGXTDecember 7, 2023 | morningstar.comIntelGenx Receives Approval to Conduct ’MONTPARK’ Montelukast VersaFilm® Phase 2 Clinical Trial in Patients with Parkinson's DiseaseNovember 14, 2023 | finance.yahoo.comIntelGenx Reminds Shareholders to Vote at Upcoming Special MeetingNovember 13, 2023 | finance.yahoo.comIntelGenx Technologies Corp. (PNK:IGXT) Q3 2023 Earnings Call TranscriptNovember 10, 2023 | insidermonkey.comIntelGenx Reports Third Quarter 2023 Financial ResultsNovember 9, 2023 | finance.yahoo.comIntelGenx Announces Co-development and Commercialization of Cannabinoid-Infused VersaFilm® Products with TilrayNovember 6, 2023 | finance.yahoo.comIntelGenx Provides RIZAFILM® U.S. Commercialization UpdateSeptember 21, 2023 | finance.yahoo.comIntelGenx Announces Closing of First Tranche of Non-Brokered Private Placement From Strategic Partner for Approximate Aggregate Gross Proceeds of US$3 Million (Including US$750,000 to be Received by the Company Once Shareholder Approvals Have Been Obtained)August 31, 2023 | finance.yahoo.comIntelGenx Technologies Corp.: IntelGenx Reports Second Quarter 2023 Financial ResultsAugust 16, 2023 | finanznachrichten.deIntelGenx Technologies Corp. (PNK:IGXT) Q2 2023 Earnings Call TranscriptAugust 15, 2023 | finance.yahoo.comIntelGenx Technologies Corp. (IGXT) Q2 2023 Earnings Call TranscriptAugust 15, 2023 | finance.yahoo.comIntelGenx Reports Second Quarter 2023 Financial ResultsAugust 14, 2023 | finance.yahoo.comIntelGenx Announces First Agreement for CDMO Packaging ServicesAugust 10, 2023 | finance.yahoo.comIntelGenx to Report Second Quarter 2023 Financial Results on August 14, 2023 – Conference Call to FollowAugust 8, 2023 | finance.yahoo.comIntelGenx Completes Enrollment for ‘BUENA’ Montelukast VersaFilm® Phase 2a Clinical Trial in Patients with Mild to Moderate Alzheimer’s DiseaseAugust 1, 2023 | finance.yahoo.comIntelGenx Announces a Change to its Board of DirectorsJuly 21, 2023 | finance.yahoo.comIntelGenx Announces Voting Results on Election of DirectorsJuly 6, 2023 | finance.yahoo.comIGXT - IntelGenx Technologies Corp.June 16, 2023 | uk.finance.yahoo.comIntelGenx Receives Amended DEL License to Conduct Third-Party TestingMay 17, 2023 | finance.yahoo.comFDA Gives Nod To IntelGenx's Migraine Solution As Revenues Plunge 32%; Q1 Results ReportMay 11, 2023 | msn.comIntelGenx Reports First Quarter 2023 Financial ResultsMay 11, 2023 | finance.yahoo.comIntelGenx to Report First Quarter 2023 Financial Results on May 11, 2023 – Conference Call to FollowMay 4, 2023 | finance.yahoo.comClosing Bell: Intelgenx Technologies Corp down on Friday (IGX)April 22, 2023 | theglobeandmail.comClosing Bell: Intelgenx Technologies Corp down on Tuesday (IGX)April 19, 2023 | theglobeandmail.comIntelGenx Technologies Corp.: IntelGenx Announces FDA Approval of RIZAFILM for the Treatment of Acute MigraineApril 17, 2023 | finanznachrichten.deIntelGenx Announces FDA Approval of RIZAFILM® for the Treatment of Acute MigraineApril 17, 2023 | finance.yahoo.com Remove Ads Get IntelGenx Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for IGXT and its competitors with MarketBeat's FREE daily newsletter. Email Address IGXT Media Mentions By Week IGXT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IGXT News Sentiment▼0.000.78▲Average Medical News Sentiment IGXT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IGXT Articles This Week▼00▲IGXT Articles Average Week Remove Ads Get IntelGenx Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for IGXT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Adaptimmune Therapeutics News Today Silence Therapeutics News Today Journey Medical News Today Elutia News Today Editas Medicine News Today Nkarta News Today Coya Therapeutics News Today Procaps Group News Today Lineage Cell Therapeutics News Today Kyverna Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:IGXT) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredIs Fort Knox Hiding Less Gold Than We Think? Find Out What That Means for YouWith gold prices recently soaring to record highs over $3,000 an ounce, and central banks rushing to accumulat...The Oxford Club | SponsoredLive Footage From Elon Musk’s “Area 51”What’s happening inside this nondescript building in South Memphis is so incredible… That Elon’s competitor...Brownstone Research | SponsoredTermination: 18F (read immediately)Have you ever heard of the government's 18F program? It helped manage digital services across the governmen...Altimetry | Sponsored“Massive Financial Reset Is Coming”The U.S. markets will see a massive reset, beginning days from now. But the "reset" isn't what you might ex...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IntelGenx Technologies Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share IntelGenx Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
